Goldman Sachs
DNTH icon

Goldman Sachs’s Dianthus Therapeutics DNTH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.79M Buy
364,592
+291,162
+397% +$5.42M ﹤0.01% 2565
2025
Q1
$1.33M Sell
73,430
-134,637
-65% -$2.44M ﹤0.01% 3631
2024
Q4
$4.54M Buy
208,067
+127,461
+158% +$2.78M ﹤0.01% 2924
2024
Q3
$2.21M Buy
80,606
+38,737
+93% +$1.06M ﹤0.01% 3305
2024
Q2
$1.08M Sell
41,869
-128,348
-75% -$3.32M ﹤0.01% 3540
2024
Q1
$5.11M Buy
+170,217
New +$5.11M ﹤0.01% 2551
2023
Q1
Sell
-38,059
Closed -$15K 5142
2022
Q4
$15K Sell
38,059
-73,702
-66% -$29.1K ﹤0.01% 4918
2022
Q3
$158K Sell
111,761
-10,626
-9% -$15K ﹤0.01% 4792
2022
Q2
$147K Sell
122,387
-39,692
-24% -$47.7K ﹤0.01% 4996
2022
Q1
$470K Sell
162,079
-24,941
-13% -$72.3K ﹤0.01% 4605
2021
Q4
$829K Buy
187,020
+15,149
+9% +$67.2K ﹤0.01% 4180
2021
Q3
$1.25M Buy
171,871
+18,646
+12% +$136K ﹤0.01% 3820
2021
Q2
$1.5M Buy
153,225
+91,641
+149% +$897K ﹤0.01% 3730
2021
Q1
$730K Sell
61,584
-15,974
-21% -$189K ﹤0.01% 4121
2020
Q4
$608K Sell
77,558
-16,678
-18% -$131K ﹤0.01% 3723
2020
Q3
$641K Buy
94,236
+17,247
+22% +$117K ﹤0.01% 3543
2020
Q2
$578K Buy
76,989
+34,115
+80% +$256K ﹤0.01% 3518
2020
Q1
$269K Buy
42,874
+20,526
+92% +$129K ﹤0.01% 3820
2019
Q4
$339K Buy
22,348
+313
+1% +$4.75K ﹤0.01% 3817
2019
Q3
$226K Sell
22,035
-2,239
-9% -$23K ﹤0.01% 3874
2019
Q2
$358K Sell
24,274
-3,744
-13% -$55.2K ﹤0.01% 3647
2019
Q1
$461K Buy
28,018
+9,675
+53% +$159K ﹤0.01% 3594
2018
Q4
$105K Buy
+18,343
New +$105K ﹤0.01% 3880
2018
Q3
Sell
-75,504
Closed -$1.02M 4130
2018
Q2
$1.02M Buy
+75,504
New +$1.02M ﹤0.01% 3187